Authorized Generic Pricing: Why They Cost Less Than Brand-Name Drugs

When you pick up a prescription, you might notice two similar-looking bottles on the counter-one with a well-known brand name, another labeled as an "authorized generic." They look almost identical. The pills are the same size, color, and shape. The instructions are the same. So why does one cost nearly half as much?

What Exactly Is an Authorized Generic?

An authorized generic is a drug that is chemically identical to a brand-name medication, manufactured in the same facility, using the same ingredients and quality controls, but sold under a different label. It’s not a knockoff. It’s not a copy. It’s the exact same product, just without the brand name.

These drugs are produced either by the original brand company itself or by a partner company with full permission from the brand owner. They operate under the original FDA-approved New Drug Application (NDA), which means they don’t need to go through the lengthy and expensive approval process that traditional generics do. That’s a big deal.

Traditional generics must file an Abbreviated New Drug Application (ANDA), prove they’re bioequivalent, and wait for FDA review. Authorized generics skip that. They’re already made in the same factory, on the same line, under the same quality standards as the brand. No extra testing. No extra paperwork. Just lower costs.

Why Do Authorized Generics Cost Less?

The answer isn’t complicated: no marketing costs.

Brand-name drugs spend billions on TV ads, doctor promotions, patient support programs, and direct-to-consumer campaigns. That’s all gone with an authorized generic. There’s no need to convince people the drug works-it already has a proven track record. The brand’s reputation is already built.

Also, no patent protection means no monopoly pricing. Once a drug’s patent expires, competition is supposed to drive prices down. But in the U.S., the first generic company to file gets 180 days of exclusive rights to sell the generic version. During that time, they often set prices high-sometimes as much as 80% of the brand price-because there’s no competition yet.

That’s where authorized generics change the game.

When a brand company launches its own authorized generic at the same time as the first generic entrant, it creates instant competition. The first generic can’t charge premium prices anymore. If they do, the authorized generic undercuts them. And because the authorized generic is made by the same company that made the brand, it’s often priced 4% to 8% below the original brand drug.

Real data backs this up. The Federal Trade Commission found that when an authorized generic enters the market alongside the first generic, retail prices drop by 4% to 8%, and wholesale prices drop by 7% to 14%. In some cases, especially with high-cost drugs like those for heart disease or mental health, the price drop was even sharper-up to 18% off the invoice price pharmacies pay.

How Do Authorized Generics Compare to Traditional Generics?

Many people assume all generics are the same. They’re not.

Traditional generics come from third-party manufacturers that have gone through the ANDA process. They’re often produced in different facilities, sometimes overseas, and may have slight differences in inactive ingredients (like fillers or coatings). While they’re required to be bioequivalent, they’re not always made in the same plant as the brand.

Authorized generics? They’re the same pill. Same factory. Same batch process. Just a different label.

Here’s a quick comparison:

Notice something? The authorized generic isn’t the cheapest. But it’s the closest to the brand in every way-except price. And that’s the point.

Real-World Examples That Changed the Game

In 2016, Mylan faced public outrage after raising the price of the EpiPen from $100 to $600. Within months, they launched an authorized generic version for $300. That wasn’t charity-it was damage control. But it worked. The authorized generic gave consumers a cheaper option, and it forced competitors to lower their prices too.

Another example: Gilead Sciences, the maker of Harvoni and Epclusa (hepatitis C drugs), launched authorized generics before their patents even expired. Why? Because they knew other companies were preparing to enter the market. By launching their own version early, they captured a chunk of the future generic market and kept prices from spiraling even higher.

These aren’t rare cases. According to IQVIA, 67% of brand-name drug manufacturers have used authorized generics for at least one product since 2010. The strategy isn’t just common-it’s standard.

Why Your Pharmacy Might Not Tell You About Them

Here’s the catch: authorized generics aren’t always easy to find.

Pharmacy Benefit Managers (PBMs) control which drugs go on insurance formularies. Some PBMs place the authorized generic on the same tier as the brand-name drug. That means you pay the same copay for both. So if your plan doesn’t push the authorized generic as the preferred option, you might never know it exists.

But if your PBM puts the authorized generic on the same tier as traditional generics, you’ll pay the lowest price possible-often less than $10 for a 30-day supply.

One 2022 study of 1.2 million Medicare Part D patients found that when authorized generics were properly positioned, medication adherence improved by 8.2 percentage points. People didn’t skip doses because they couldn’t afford them.

Ask your pharmacist: "Is there an authorized generic for this drug?" If they don’t know, ask your insurance provider. Sometimes, it takes a little digging to get the best price.

What’s Next for Authorized Generics?

The Inflation Reduction Act of 2023 capped out-of-pocket drug costs for Medicare beneficiaries at $2,000 per year. That’s good news-but it also means insurers and PBMs are under more pressure to find the cheapest options.

Authorized generics are now more important than ever. With 137 active authorized generics listed by the FDA as of October 2023, and more coming every quarter, this strategy isn’t fading. It’s growing.

Industry analysts predict authorized generics will continue to capture 15% to 25% of the generic market share through 2030. That’s billions in savings for patients, and billions less spent by insurers.

But there’s a dark side. Some critics argue that brand companies use authorized generics as a tactic to delay true competition. By launching their own generic, they can settle patent lawsuits and keep other manufacturers out longer. The FTC has raised concerns about this. But even if the strategy is sometimes used to slow competition, the result is still lower prices-at least in the short term.

Bottom line: authorized generics aren’t magic. But they’re real. And they’re saving people money right now.

How to Get the Best Price on Your Prescription

• Always ask your pharmacist: "Is there an authorized generic for this drug?"
• Check your insurance formulary-see if the authorized generic is listed as preferred.
• Use a price comparison app like GoodRx or RxSaver to compare brand, authorized generic, and traditional generic prices.
• If your plan doesn’t cover the authorized generic, ask if you can switch to it for a lower copay.
• Don’t assume the brand is better. Authorized generics are identical in every way that matters.

You don’t need to be a pharmacy expert to save money. You just need to ask the right questions.

If you’re paying full price for a brand-name drug, you’re likely overpaying. Authorized generics exist to change that. And they’re working.